We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A New Molecular Target for Especially Aggressive Cancers

News   Apr 08, 2020 | Original story from the University of Geneva (UNIGE)

 
A New Molecular Target for Especially Aggressive Cancers

Three-dimensional lung (green) and tumors (red) and corresponding X-ray scans (black and white) at weeks 0, 6, and 12 after tumour onset (left: mouse with intact FKBP10; right: mouse with inhibition of FKBP10). At week 12, tumour growth is greatly reduced upon FKBP10 deletion. Credit: UNIGE Coppari/Collart labs

 
 
Advertisement
 

RELATED ARTICLES

Cells Inside Cells: The Bacteria That Live in Cancer Cells

News

Cancer cells are comfy havens for bacteria. That conclusion arises from a rigorous study of over 1,000 tumor samples of different human cancers, which found bacteria living inside the cells of all the cancer types – from brain to bone to breast cancer – and even identified unique populations of bacteria residing in each type of cancer.

READ MORE

Blood Markers of Fitness Identified

News

A simple blood test may be able to determine how physically fit you are, according to a new study conducted by scientists at the Stanford University School of Medicine.

READ MORE

FDA Grants Fast Track Designation to Onvansertib for Second-line Treatment of KRAS-mutated Colorectal Cancer

News

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to onvansertib, an oral and highly-selective Polo-like Kinase 1 (PLK1) inhibitor, for the second-line treatment of patients with KRAS-mutated metastatic colorectal cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE